Gilead Sciences (GILD) Declares $0.43 Quarterly Dividend; 1.6% Yield

Go back to Gilead Sciences (GILD) Declares $0.43 Quarterly Dividend; 1.6% Yield

Gilead Sciences (GILD) raises Revenue Guidance Following 3Q Beat; Maxim Group Reiterates Buy

October 28, 2015 1:47 PM EDT

Maxim Group reiterated a Buy rating on Gilead Sciences (NASDAQ: GILD), and raised the price target to $137.00 (from $129.00), following the company's 3Q earnings results. Gilead delivered a very strong quarter well ahead of street estimates. Gilead raised guidance for full year... More